Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics

Toxicology and Applied Pharmacology

Volumn 242, Issue 2, 2010, Pages 126-135

  Chen, Shu Hui ^a   Wang, Yi Wen ^b   Hsu, Jue Liang ^a   Chang, Hong Yi ^b   Wang, Chi Yun ^b   Shen, Po Tsun ^a   Chiang, Chi Wu ^b   Chuang, Jing Jing ^c   Tsai, Hung Wen ^d   Gu, Po Wen ^e   Chang, Fang Chih ^a   Liu, Hsiao Sheng ^b   Chow, Nan Haw ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Arsenic; Bladder; Carcinogenesis; Isoflavones; Nucleophosmin; Proteomics

Indexed keywords

ARSENIC; ISOFLAVONE; NUCLEOPHOSMIN; STABLE ISOTOPE;

APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CELL CYCLE REGULATION; CELL IMMORTALIZATION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MOLECULAR DYNAMICS; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION; UPREGULATION;

ARSENIC; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOGENS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; HUMANS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEOMICS; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; URINARY BLADDER NEOPLASMS;

GLYCINE MAX;

EID: 71149116759     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.09.016     Document Type: Article

References (35)

1. Ahn J.Y., Liu X., Cheng D., Peng J., Chan P.K., Wade P.A., and Ye K. Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol. Cell 18 (2005) 435-445
2. Chan W.Y., Liu Q.R., Borjigin J., Busch H., Rennert O.M., Tease L.A., and Chan P.K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28 (1989) 1033-1039
3. Chen C.J., Chuang Y.C., You S.L., Lin T.M., and Wu H.Y. A retrospective study on malignant neoplasms of bladder, lung, and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 53 (1986) 399-405
4. Cheng H.L., Liu H.S., Lin Y.J., Chen H.W., Hsu P.Y., Chang T.Y., Ho C.L., Tzai T.S., and Chow N.H. Co-expression of RON and MET is a prognostic indicator for patients with transitional cell carcinoma of the bladder. Br. J. Cancer 9 (2005) 1906-1914
5. Chiou H.Y., Hsueh Y., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin S.N., Huang C.H., and Chen C.J. Incidence of internal cancers and ingested inorganic arsenic: A 7-year follow-up study in Taiwan. Cancer Res. 55 (1995) 1296-1300
6. Chow N.H., Guo Y.L., Lin S.N., Su H.J., Tzai T.S., Guo H.R., and Su I.J. Clinicopathologic features of bladder cancer associated with chronic exposure to arsenic. Br. J. Cancer 75 (1997) 1708-1710
7. Chow N.H., Liu H.S., and Chan S.H. The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin. Cancer Res. 6 (2000) 3595-3599
8. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., Cano M., St John M., Yamamoto S., Lu X., and Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15 (2002) 1150-1157
9. Darimont C., Zbinden I., Avanti O., Leone-Vautravers P., Gi|4502101usti V., Burckhardt P., Pfeifer A.M.A., and Macé K. Reconstitution of telomerase activity combined with HPV-E7 expression allows human preadipocytes to preserve their differentiation capacity after immortalization. Cell Death Differ 10 (2003) 1025-1031
10. Derenzini M., Sirri V., Trere D., and Ochs R.L. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab. Invest. 73 (1995) 497-502
11. Feuerstein N., and Mond J.J. "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J. Biol. Chem. 262 (1987) 11389-11397
12. Feuerstein N., Mond J.J., Kinchington P.R., Hickey R., Karjalainen Lindsberg M.L., Hay I., and Ruyechan W.T. Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim. Biophys. Acta 1087 (1990) 127-136
13. Fu Q., and Li L.J. De novo sequencing of neuropeptides using reductive isotopic methylation and investigation of ESI QTOF MS/MS fragmentation pattern of neuropeptides with N-terminal dimethylation. Anal. Chem 75 (2005) 7783-7795
14. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17 (1999) 994-999
15. Hsu J.L., Huang S.Y., Chow N.H., and Chen S.H. Dimethyl stable-isotope labeling for quantitative proteomics. Anal. Chem. 75 (2003) 6843-6852
16. Hsu P.Y., Liu H.S., Ho C.L., Cheng H.L., Tzai T.S., Chang T.Y., Guo H.R., and Chow N.H. Collaboration of RON and EGFR in human bladder carcinogenesis. J. Urol. 176 (2006) 2262-2267
17. Imai H., Ochs R.L., Kiyosawa K., Furuta S., Nakamura R.M., and Tan E.M. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am. J. Pathol. 140 (1992) 859-870
18. Kligerman A.D., and Tennant A.H. Insights into the carcinogenic mode of action of arsenic. Toxicol. Appl. Pharmacol. 222 (2007) 281-288
19. Lee S.Y., Park J.H., Kim S., Park E.J., Yun Y., and Kwon J. A proteomics approach for the identification of nucleophosmin and heterogeneous nuclear ribonucleoprotein C1/C2 as chromatin-binding proteins in response to DNA double-strand breaks. Biochem. J. 388 (2005) 7-15
20. Lindström M.S., and Zhang Y. Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation. J. Biol. Chem. 283 (2008) 15568-15576
21. Nozawa Y., Van Belzen N., Van der Made A.C., Dinjens W.N., and Bosman F.T. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J. Pathol. 178 (1996) 48-52
22. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250 (1975) 4007-4021
23. Patterson S.D., Grossman J.S., D'Andrea P., and Latter G.I. Reduced numatrin/B23/ nucleophosmin labeling in apoptotic Jurkat T-lymphoblasts. J. Biol. Chem. 270 (1995) 9429-9436
24. Szanto A., Bognar Z., Szigeti A., Szabo A., Farkas L., and Gallyas F.Jr.. Critical role of Bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells. Anticancer Res. 29 (2009) 159-164
25. Sen B., Wolf D.C., Turpaz Y., Bugrim A., Retief J., and Hester S.D. Identification of interspecies concordance of mechanisms of arsenic-induced bladder cancer. Toxicol. In Vitro 21 (2007) 1513-1529
26. Shields L.B., Gercel-Taylor C., Yashar C.M., Wan T.C., Katsanis W.A., Spinnato J.A., and Taylor D.D. Induction of immune responses to ovarian tumor antigens by multiparity. J. Soc. Gynecol. Investig. 4 (1997) 298-304
27. Su P.F., Hu Y.J., Ho I.C., and Cheng Y.M. Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ. Health Perspect. 114 (2006) 394-403
28. Su S.J., Yeh T.M., Lei H.Y., and Chow N.H. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin. Cancer Res. 6 (2000) 230-236
29. Subong E.N., Shue M.J., Epstein J.I., Briggman J.V., Chan P.K., and Partin A.W. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate 39 (1999) 298-304
30. Tseng W.P. Effects and dose-response relationship of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19 (1977) 109-119
31. Tsui K.H., Cheng A.J., Chang P.L., Pan T.L., and Yung B.Y. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 64 (2004) 839-844
32. van Belzen N., Dinjens W.N., Eussen B.H., and Bosman F.T. Expression of differentiation-related genes in colorectal cancer: possible implications for prognosis. Histol. Histopathol. 13 (1998) 1233-1242
33. Yan H., Wang N., Weinfeld M., Cullen W.R., and Le X.C. Identification of arsenic-binding proteins in human cells by affinity chromatography and mass spectrometry. Anal. Chem. (2009) Epub ahead of print
34. Yu D.S., Hsieh D.S., and Chang S.Y. Detection of chromosomal alterations in bladder cancer by comparative genomic hybridization. B.J.U. Int. 87 (2001) 889-893
35. Yun J.P., Miao J., Chen G.G., Tian Q.H., Zhang C.Q., Xiang J., Fu J., and Lai P.B.S. Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopatho-logical parameters. Br. J. Cancer 96 (2007) 477-484